Company intelligence / Profile preview

Cisbio

Codolet, Occitania, Francecisbio.eu ↗

Ownership: Private
Employees: ~150
Development stage: Other

Overview

Cisbio has developed over ~600 proprietary assays and reagents based on its patented HTRF technology. These products enable high-throughput drug screening, GPCR investigation, kinase activity measurement, cAMP quantification, and more. Their platforms are widely adopted by pharmaceutical companies, biotech firms, CROs/CMOs/CDMOs, and academic labs globally. The company’s technologies have become industry standards in many aspects of cell signaling research and drug discovery workflows[1][3][5].

Therapeutic areas: OncologyMetabolic DisordersImmunology
Modalities: ImmunoassayMonoclonal antibodySmall moleculePeptidesProtein
Industry: Drug Discovery Services

Beyond the preview

Go deeper on Cisbio.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cisbio.

Explore the full profile